These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32909272)

  • 1. Prevalence of SARS-COVID-19 serum IgG antibodies amongst staff on an acute surgical unit.
    Isherwood J; Winyard J; Karki B; Chung WY; Layton G; Issa E; Garcea G; Dennison AR
    Br J Surg; 2020 Nov; 107(12):e576-e577. PubMed ID: 32909272
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis.
    Indenbaum V; Koren R; Katz-Likvornik S; Yitzchaki M; Halpern O; Regev-Yochay G; Cohen C; Biber A; Feferman T; Cohen Saban N; Dhan R; Levin T; Gozlan Y; Weil M; Mor O; Mandelboim M; Sofer D; Mendelson E; Lustig Y
    PLoS One; 2020; 15(11):e0241164. PubMed ID: 33227020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 IgG antibodies in the current COVID-19 pandemic amongst co-workers at a UK renal transplant centre.
    Black JT; Haroon U; Barnes SC; Mayaleh S; Bagul A
    Transpl Int; 2021 Feb; 34(2):382-383. PubMed ID: 33320975
    [No Abstract]   [Full Text] [Related]  

  • 5. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity.
    Kong WH; Zhao R; Zhou JB; Wang F; Kong DG; Sun JB; Ruan QF; Liu MQ
    Virol Sin; 2020 Dec; 35(6):752-757. PubMed ID: 32705575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 IgG seroprevalence among medical staff in a general hospital that treated patients with COVID-19 in Japan: retrospective evaluation of nosocomial infection control.
    Hibino M; Iwabuchi S; Munakata H
    J Hosp Infect; 2021 Jan; 107():103-104. PubMed ID: 33039454
    [No Abstract]   [Full Text] [Related]  

  • 11. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.
    Brehm TT; Schwinge D; Lampalzer S; Schlicker V; Küchen J; Thompson M; Ullrich F; Huber S; Schmiedel S; Addo MM; Lütgehetmann M; Knobloch JK; Schulze Zur Wiesch J; Lohse AW
    Int J Hyg Environ Health; 2021 Mar; 232():113671. PubMed ID: 33338782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
    Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
    PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes.
    Batra M; Tian R; Zhang C; Clarence E; Sacher CS; Miranda JN; De La Fuente JRO; Mathew M; Green D; Patel S; Bastidas MVP; Haddadi S; Murthi M; Gonzalez MS; Kambali S; Santos KHM; Asif H; Modarresi F; Faghihi M; Mirsaeidi M
    Sci Rep; 2021 Feb; 11(1):3455. PubMed ID: 33568776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates.
    Liu T; Hsiung J; Zhao S; Kost J; Sreedhar D; Hanson CV; Olson K; Keare D; Chang ST; Bliden KP; Gurbel PA; Tantry US; Roche J; Press C; Boggs J; Rodriguez-Soto JP; Montoya JG; Tang M; Dai H
    Nat Biomed Eng; 2020 Dec; 4(12):1188-1196. PubMed ID: 33122853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness and limitations of implementing rapid tests for the diagnosis of COVID-19 in Latin America.
    García-Díaz G; Montalvo-Varela E; Cano-Pérez E; da Silva Francisco Junior R; Rodriguez-Morales A
    Infez Med; 2020 Dec; 28(4):642-644. PubMed ID: 33257642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Not Available].
    Béguelin A
    Rev Med Suisse; 2021 Jan; 17(723):234. PubMed ID: 33507668
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.
    Mazzini L; Martinuzzi D; Hyseni I; Benincasa L; Molesti E; Casa E; Lapini G; Piu P; Trombetta CM; Marchi S; Razzano I; Manenti A; Montomoli E
    J Immunol Methods; 2021 Feb; 489():112937. PubMed ID: 33253698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.